Are There New Research or Advances Related to Calcitonin and Cancer?
Recent research is focusing on enhancing the specificity and sensitivity of calcitonin measurements. Advances in molecular biology are also exploring the genetic mutations associated with medullary thyroid carcinoma, such as RET proto-oncogene mutations, to provide more comprehensive diagnostic and prognostic information. Additionally, novel therapies targeting these genetic pathways are under investigation, potentially improving outcomes for patients with this type of cancer.
